Will any ServiceNow insider (CEO, CFO, or Board member) make an additional discretionary open-market share purchase by September 30, 2026?

The 7-month resolution window (March-September 2026) provides ample time, but base rates for discretionary insider purchases at large-cap tech companies are low. CEO McDermott's purchase was rare and historically significant for ServiceNow -- the committee noted this explicitly. However, three factors weigh against additional buying: (1) large RSU grants in Feb 2026 (CEO 106K shares, CFO 67K, COO 86K) reduce the marginal benefit of open-market purchases since insiders are already gaining significant equity exposure; (2) the active DOJ investigation creates legal/compliance friction that may practically prevent purchases even if insiders want to buy; (3) no other insider has purchased despite the stock being 50% below highs for weeks, suggesting the CEO's action was idiosyncratic conviction rather than a consensus view among management.

The question asks about ANY insider making an additional purchase, which includes the CEO buying again. This broadens the probability somewhat. However, the analysis data reveals a clear pattern: despite stock trading at ~50% off highs for weeks, only one insider acted. The CFO's proposed Form 144 sales (832 shares, 0.86% of holdings) suggest at minimum a neutral-to-slightly-bearish posture, not a buying mindset. Board directors have shown zero purchasing activity. The DOJ overhang is particularly relevant -- the Desai departure for policy violations likely makes compliance departments extra cautious about approving discretionary trades. The committee's unresolved debate about whether DOJ overhang makes insiders reluctant is well-founded. I weight this constraint heavily: legal counsel at a company under DOJ investigation will likely advise against discretionary purchases to avoid any appearance of trading on inside information about the investigation's trajectory.

The CEO's purchase was deliberately signaling -- he adopted a non-10b5-1 arrangement on Feb 13 and executed on Feb 27, buying at depressed levels after the DOJ probe disclosure. This was eyes-open conviction. For the question of whether ANY insider buys again over 7 months, I consider: (1) the CEO himself may buy again if the stock remains depressed or declines further -- his $3M purchase was modest relative to his $16.6M vested holdings and he clearly views the stock as undervalued; (2) the resolution window spans two earnings cycles (Q1 report ~April, Q2 report ~July), which create natural windows for insider purchases; (3) if the DOJ investigation shows progress toward resolution (settlement, reduced scope), the compliance friction diminishes. The Myth Meter's note that CEO buying at 50% off suggests management does not expect severe DOJ outcome is relevant -- if that view spreads to other executives, additional purchases become more likely. But I anchor on the revealed preference: 2+ weeks at depressed prices with only one buyer.

Discretionary insider purchases at large-cap companies are rare events. The committee data shows 20 Form 4 filings reviewed with exactly one purchase. The 7-month window helps but does not change the fundamental calculus: insiders with large RSU grants (totaling 260K+ shares across three executives) have limited incentive to deploy personal capital when they are already receiving substantial equity compensation. The DOJ investigation is a significant practical barrier -- general counsel offices restrict trading windows aggressively during active investigations. The CEO's purchase was unusual precisely because it was unusual; expecting it to catalyze a cluster requires optimism not supported by the data.

The question is broad: ANY insider, ANY purchase, over 7 months. This is a long window. The CEO has demonstrated willingness to buy at these levels and his $3M purchase was small relative to his means. If the stock remains near $100-110 or drops further, a repeat CEO purchase is plausible -- he set up the non-10b5-1 arrangement infrastructure. The CFO and COO each hold $7-10M in vested shares, showing they already have meaningful exposure, but they could still make a symbolic purchase to signal alignment. However, the DOJ overhang is the strongest counterargument. Companies under investigation typically have their insider trading compliance policies tightened significantly. Even willing buyers may be unable to execute.

I weigh the revealed preference data heavily. The stock has been at depressed levels (50% off highs) for a meaningful period. Every insider in the C-suite has millions in vested holdings and thus the financial capacity to buy. Yet only the CEO acted. This is informative -- it suggests the other insiders either do not share the CEO's conviction, face compliance restrictions, or simply do not view open-market purchases as worth the signal. The large Feb 2026 RSU grants further reduce incentive. I assign LOW confidence because the 7-month window introduces significant uncertainty about future stock price movements and DOJ resolution timeline -- events that could change the calculus dramatically but are unpredictable.

CEO already demonstrated buying willingness at these levels. 7-month window is long. But DOJ investigation and large RSU grants work against additional purchases. Base rate for discretionary insider buying at large-cap tech is low. Slight lean toward NO given zero other insiders have shown interest despite depressed prices.

Only 1 of 20+ Form 4 filings showed a purchase. RSU grants of 260K shares reduce incentive for discretionary buying. DOJ probe makes compliance departments restrictive. The CEO's purchase was the exception, not the start of a pattern. 7 months helps but base rate is low.

Broad criteria (any insider) and long window (7 months) favor YES. CEO may repeat given modest initial purchase vs. holdings. But no other insider has shown buying interest and DOJ creates compliance barriers. Net assessment leans slightly NO.